Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
This study is currently recruiting participants.
Verified April 2017 by George E. Peoples, Cancer Insight, LLC
George E. Peoples
Galena Biopharma, Inc.
Information provided by (Responsible Party):
George E. Peoples, Cancer Insight, LLC
First received: March 25, 2012
Last updated: April 5, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||June 2020|
|Estimated Primary Completion Date:||June 2019 (Final data collection date for primary outcome measure)|